|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Century Therapeutics, Inc. (IPSC) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
54,820,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Century Therapeutics is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with unmet medical need. Co.'s primary product candidate, CNTY-101, is an allogeneic, chimeric antigen receptors (CAR)-induce pluripotent stem cell-derived (iPSC-derived) natural killer (iNK) cell therapy that has been engineered to express CD19 CAR, soluble IL-15, an epidermal growth factor receptor safety switch, and also contains gene edits needed to incorporate Allo-Evasion™ technology. CNTY-103 is Co.'s main product candidate targeting a solid tumor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
65,170 |
70,189 |
70,189 |
1,129,900 |
| Total Sell Value |
$306,783 |
$327,573 |
$327,573 |
$8,034,062 |
| Total People Sold |
3 |
3 |
3 |
5 |
| Total Sell Transactions |
7 |
11 |
11 |
16 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Borges Luis |
Chief Scientific Officer |
• – – |
2023-03-23 |
4 |
OE |
$1.03 |
$227,558 |
D/D |
220,930 |
264,680 |
|
- |
|
| Borges Luis |
Chief Scientific Officer |
• – – |
2023-03-22 |
4 |
S |
$3.72 |
$244,640 |
D/D |
(65,698) |
43,750 |
|
- |
|
| Borges Luis |
Chief Scientific Officer |
• – – |
2023-03-22 |
4 |
OE |
$1.03 |
$67,669 |
D/D |
65,698 |
109,448 |
|
- |
|
| Borges Luis |
Chief Scientific Officer |
• – – |
2023-03-21 |
4 |
S |
$3.77 |
$239,870 |
D/D |
(63,616) |
43,750 |
|
- |
|
| Borges Luis |
Chief Scientific Officer |
• – – |
2023-03-21 |
4 |
OE |
$1.03 |
$65,524 |
D/D |
63,616 |
107,366 |
|
- |
|
| Borges Luis |
Chief Scientific Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
43,750 |
|
- |
|
| Diem Michael Craig |
Chief Business Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
123,238 |
|
- |
|
| Farid Adrienne |
Chief Operations Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
117,968 |
|
- |
|
| Carr Douglas |
VP Finance & Operations |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
200,545 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2022-08-09 |
4 |
AS |
$0.00 |
$0 |
D/D |
(364,800) |
11,452,014 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2022-08-09 |
4 |
AS |
$13.03 |
$7,166,610 |
D/D |
(550,000) |
11,816,814 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2022-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(178,996) |
12,366,814 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2021-12-23 |
4 |
AS |
$0.00 |
$0 |
D/D |
(371,004) |
12,545,810 |
|
- |
|
| Casdin Eli |
Director |
– • – |
2021-06-22 |
4 |
B |
$20.00 |
$15,000,000 |
I/I |
750,000 |
3,206,380 |
2.1 |
- |
|
| Casdin Eli |
Director |
– • – |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,456,380 |
2,456,380 |
|
- |
|
| Fujifilm Holdings Corp |
10% Owner |
– – • |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,974,404 |
6,955,207 |
|
- |
|
| Bayer World Investments B.v. |
10% Owner |
– – • |
2021-06-22 |
4 |
B |
$20.00 |
$15,000,000 |
D/D |
750,000 |
12,675,838 |
2.45 |
- |
|
| Bayer World Investments B.v. |
10% Owner |
– – • |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11,925,838 |
11,925,838 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2021-06-22 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
714,095 |
1.5 |
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
614,095 |
614,095 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,936,011 |
12,916,814 |
|
- |
|
| Farid Adrienne |
Chief Operations OfficerOffice |
• – – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
74,218 |
|
- |
|
| Versant Vantage Ii Gp-Gp, Llc |
10% Owner |
– – • |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,980,803 |
|
- |
|
| Levitsky Hyam |
President of R&DOfficer |
• – – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
536,544 |
|
- |
|
| Jimenez Joseph |
Director |
– • – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
494,346 |
|
- |
|
55 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
